Ever wonder why a biotech stock trades down, even after announcing data with "successful results"? More likely than not, the data was not actually successful. The cherry-picked results that are shared might seem like positive data, but in reality, the overall study did not meet expectations. This is especially true when companies start discussing sub-po…
© 2024 Bohdan (Bo) Khomtchouk, Ph.D.
Substack is the home for great culture